Abstract:AbstractBackgroundThe heterogeneity of neurodegenerative diseases, including Alzheimer’s disease (AD), has hampered precision diagnosis and treatment. Machine learning methods enable the identification of genetically‐explained disease subtypes with distinct brain phenotypes.MethodGene‐SGAN is a novel, multi‐view, weakly‐supervised deep clustering method that jointly considers phenotypic and genetic data, thereby deriving subtypes of disease‐related brain changes with genetic associations. We apply the method to derive subtypes related to AD. Analyses used structural MRIs and whole‐genome sequencing data from the Alzheimer’s Disease Neuroimaging Initiative (1,533 participants, including controls and patients with Mild Cognitive Impairment (MCI) and AD).ResultGene‐SGAN identified four distinct subtypes within MCI/AD: A1, normal anatomy; A2, focal medial temporal lobe (MTL) atrophy; A3, severe atrophy in neocortex and MTL; A4, severe cortical but relatively modest MTL atrophy (Figure 1). The four subtypes reveal significant differences in seven known AD‐related genetic variants (Figure 2). The identified subtype‐associated SNPs not only resemble previous findings, but also suggest genetic protective effects contributing to the observed resilience (A1), potential inflammatory mechanisms underlying subtypes (A2&A3), and the effect of SNPs on atypical atrophy patterns of AD (A4). Clinically, A1 and A3 participants showed the best and the worst cognitive performances (Figure 3). A3 participants had the most abnormal CSF Aβ (p<0.001 vs. A1&A4 and p = 0.039 vs. A2), and exhibited the highest white matter hyperintensity (WMH) volumes (p<0.001 vs. A1&A4 and p = 0.017 vs. A2). However, A2 participants showed significantly higher CSF phospho‐tau than A3 participants (p = 0.019). A4 participants were the youngest group (p<0.001 vs. all other groups), suggesting the inclusion of early onset AD participants, who have a higher prevalence of hippocampal‐sparing variants such as posterior cortical atrophy. The four genetically‐associated subtypes also possess significant differences in a large set of plasma/CSF biomarkers, which are related to distinct biological mechanisms contributing to the heterogeneity of AD.ConclusionDeep learning revealed four morphologic/genetic MCI/AD subtypes. The derived subtypes display distinct neuroanatomical patterns and genetic determinants and also differ in many clinically interpretable biomarkers. These subtypes provide potential for drug discovery and repurposing, optimization of clinical trial recruitment, and personalized medicine based on an individual’s genetic profile.

Diagnosis-Guided Deep Subspace Clustering Association Study for Pathogenetic Markers Identification of Alzheimer's Disease Based on Comparative Atlases

Exploring Imaging Genetic Markers of Alzheimer's Disease Based on a Novel Nonlinear Correlation Analysis Algorithm

Mining Outcome-Relevant Brain Imaging Genetic Associations Via Three-Way Sparse Canonical Correlation Analysis in Alzheimer'S Disease

Transcriptome-guided Amyloid Imaging Genetic Analysis Via a Novel Structured Sparse Learning Algorithm.

A Novel Longitudinal Phenotype-Genotype Association Study Based on Deep Feature Extraction and Hypergraph Models for Alzheimer's Disease

Multigroup Recognition of Dementia Patients with Dynamic Brain Connectivity under Multimodal Cortex Parcellation

A Bayesian Group Sparse Canonical Correlation Analysis Method for Brain Imaging Genomics

Probability Connectivity-Based Multimodality Regression Analysis for Associating Disease-Specific Multimodal Brain Imaging Phenotypes with Genetic Risk Factors.

Mining High-Level Imaging Genetic Associations via Clustering AD Candidate Variants with Similar Brain Association Patterns

Multivariate Deep Learning Classification of Alzheimer’s Disease Based on Hierarchical Partner Matching Independent Component Analysis

Identifying Alzheimer's Disease-Related Brain Regions from Multi-Modality Neuroimaging Data Using Sparse Composite Linear Discrimination Analysis.

Mapping the Genetic-Imaging-Clinical Pathway with Applications to Alzheimer's Disease

Discovering Alzheimer’s Disease Subtypes with Imaging and Genetic Signatures Via Multi‐view Weakly‐supervised Deep Clustering

Learning Brain Connectivity Sub-networks by Group- Constrained Sparse Inverse Covariance Estimation for Alzheimer's Disease Classification

Multimodal Data Analysis of Alzheimer's Disease Based on Clustering Evolutionary Random Forest

Research on Pathogenic Hippocampal Voxel Detection in Alzheimer's Disease Using Clustering Genetic Random Forest

Exploration of Imaging Genetic Biomarkers of Alzheimer's Disease Based on a Machine Learning Method

Identifying Disease-related Brain Imaging Quantitative Traits and Related Genetic Variations via A Bidirectional Association Learning Method.

Joint Association Discovery and Diagnosis of Alzheimer's Disease by Supervised Heterogeneous Multiview Learning.

Discovery of Genetic Biomarkers for Alzheimer's Disease Using Adaptive Convolutional Neural Networks Ensemble and Genome-Wide Association Studies

Pathology Steered Stratification Network for Subtype Identification in Alzheimer's Disease